Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Total 13F shares
-
21,329,258
-
Share change
-
-294,763
-
Total reported value
-
$1,481,500,793
-
Put/Call ratio
-
119%
-
Price per share
-
$69.56
-
Number of holders
-
183
-
Value change
-
-$17,904,382
-
Number of buys
-
85
-
Number of sells
-
82
Institutional Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q3 2020
As of 30 Sep 2020,
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) was held by
183 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,329,258 shares.
The largest 10 holders included
ROYAL BANK OF CANADA, RENAISSANCE TECHNOLOGIES LLC, GOLDMAN SACHS GROUP INC, STATE STREET CORP, VANGUARD GROUP INC, BlackRock Inc., DIMENSIONAL FUND ADVISORS LP, Aperio Group, LLC, NORTHERN TRUST CORP, and SCHRODER INVESTMENT MANAGEMENT GROUP.
This page lists
183
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.